| HaloPROTAC 2 |
1799506-06-1 |
1799506-06-1 |
| KI-696 |
KI-696 |
1799974-70-1 |
| L-Phenylalanine, N-methyl-L-valyl-L-valyl-(3R,4S,5S)-3-methoxy-5-methyl-4-(methylamino)heptanoyl-(αR,βR,2S)-β-methoxy-α-methyl-2-pyrrolidinepropanoyl-, sodium salt (1:1) |
MMAF SODIUM |
1799706-65-2 |
| BIIB068 |
BIIB068 |
1798787-27-5 |
| 2-Fluoro-α-(2-methyl-1-oxopropyl)-γ-oxo-N,β-diphenyl-benzenebutanamide |
阿托伐他汀钙杂质35 |
1797905-42-0 |
| 4-amino-N-(6-chloropyridazin-3-yl)-2,3,5,6-tetradeuteriobenzenesulfonamide |
4-amino-N-(6-chloropyridazin-3-yl)-2,3,5,6-tetradeuteriobenzenesulfonamide |
1795037-54-5 |
| N-(6-Chloro-7-methoxy-9H-pyrido[3,4-b]indol-8-yl)-2-methyl-3-pyridinecarboxamide dihydrochloride |
MLN120B DIHYDROCHLORIDE |
1782573-78-7 |
| ERK-IN-1 |
ERK-IN-1 (COMPOUND B) |
1715025-32-3 |
| N-((3R,4R)-4-fluoro-1-(6-((3-methoxy-1-methyl-1H-pyrazol-4-yl)amino)-9-methyl-9H-purin-2-yl)pyrrolidin-3-yl)acrylamide |
PF-06747775 |
1776112-90-3 |
| ML233 |
ML233 |
1776055-05-0 |
| 4(3H)-Quinazolinone, 2-[[4-[2-(4-chlorophenoxy)acetyl]-1-piperazinyl]methyl]-3-[4-(1-methylethoxy)[1,1'-biphenyl]-3-yl]- |
4(3H)-Quinazolinone, 2-[[4-[2-(4-chlorophenoxy)acetyl]-1-piperazinyl]methyl]-3-[4-(1-methylethoxy)[1,1'-biphenyl]-3-yl]- |
1695533-44-8 |
| Vipivotide tetraxetan Linker |
Vipivotide tetraxetan Linker |
1703768-74-4 |
| PSMA-617 |
1702967-37-0 |
1702967-37-0 |
| BCRP-IN-1 |
1699720-85-8 |
1699720-85-8 |
| ICG amine |
吲哚菁绿ICG AMINE |
1686147-55-6 |
| 3-(2-Methyl-4-pyrimidinyl)-1-(phenylmethyl)-1H-pyrrolo[2,3-c]pyridine |
3-(2-Methyl-4-pyrimidinyl)-1-(phenylmethyl)-1H-pyrrolo[2,3-c]pyridine |
1679330-37-0 |
| GNE-6468 |
化合物 T15404 |
1677668-27-7 |
| Cyclopropene Cyanine 7 amine |
Cy7-氨基 |
1650559-73-1 |
| FD-IN-1 |
FD-IN-1 |
1646682-14-5 |
| Eptinezumab |
依普奈珠单抗 |
1644539-04-7 |
QQ
微信
